We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

Immunotherapy Response Prediction in Urothelial Cancer
Industry Insight

While immunotherapy holds great promise for cancer treatment, challenges persist around limited response rate and severe immune-related adverse events. We caught up with Dr. Georg Lautscham, CEO of Protagen, to find out how the prediction of immunotherapy response can be improved for people with urothelial cancer.

Read More

Developing Therapies to Fight Cancer and Autoimmune Diseases
Industry Insight

We recently spoke to Alexis Peyroles, CEO at OSE Immunotherapeutics to hear more about the findings of their recent study, describing, for the first time ever, the in vivo MOA of interleukin 7 receptor alpha (IL-7Rα) monoclonal antibodies, suggesting therapeutic efficacy in controlling chronic inflammation.

Read More

Sustainability Through Innovation
Industry Insight

With growing pressure on labs to reduce waste and improve sustainability, we spoke to the Sustainability Forum at Agilent to learn more about what the company are doing to help their customers achieve their sustainability goals.

Read More

Tackling Antibiotic-resistance: Nitric Oxide-based Treatments for Respiratory Diseases
Industry Insight

The failure of conventional antibiotics to treat numerous antibiotic-resistant infections necessitates the development of new agents – as a natural anti-microbial nitric oxide holds particular promise.

Read More

A Move Towards Precise Management of Bacterial Infections
Industry Insight

Following the recent FDA approval of a procalcitonin assay, we spoke with a representative from Fujirebio Diagnostics, Inc. to learn how measuring this important biomarker will improve the healthcare landscape.

Read More

Developing Bispecific Antibodies
Industry Insight

Bispecific antibodies (bsAbs) harness the specificities of two antibodies and combine them to simultaneously recognize different antigens or epitopes. This ‘two-target’ functionality has meant that interest in their use for therapeutic applications has increased considerably. We spoke to GenScript’s Liusong Yin, PhD, and Jie Ma, to learn more about bispecific antibodies and the associated challenges developing them.

Read More

A New Generation of Flow Cytometers Advances Multiomics
Industry Insight

Flow cytometry allows the analysis of physical and biochemical features of cells. Advances in machine that can characterize and sort cells will allow researchers to look deeper than ever before into the proteome and transcriptome. We talk with Bob Balderas, VP Market Development at BD on how the cutting-edge machines like the FACSymphony S6 cell sorter incorporate new technology and advance multiomics research.

Read More

Overcoming Challenges in Clinical Microbiology Labs with Informatics and Automation
Industry Insight

We spoke to Steve Conly, Vice President & General Manager, Microbiology for BD Diagnostics Systems, to learn more about the challenges facing clinical microbiology labs, and how informatics and automation solutions can help overcome these.

Read More

Point-of-care Diagnostic Test for UTIs to Help Tackle Antimicrobial Resistance
Industry Insight

We spoke to Barbara Fallowfield, Commercial Manager, Mologic, to learn how improvements in diagnostics could help clinicians to overcome current antimicrobial stewardship challenges and tackle antimicrobial resistance.

Read More

Revolutionizing the World of Pipetting
Industry Insight

Necessity is the mother of invention, and nowhere is this more clearly demonstrated than in the laboratory. We caught up with Alex Studer, VP of Marketing and Innovation at INTEGRA Biosciences, to discuss the company’s aim to transform the world of pipetting.

Read More

 
Advertisement